In this article, we provide an overview of the potential role of HGF for the treatment of degenerative joint disease and discuss the HGF/c-Met system, anticipated to be of value for identifying causes and therapies for degenerative disorders of the synovial joint and spine. The gene discussed is MET; the disease is osteoarthritis.